Expression of testis-specific genes, TEX101 and ODF4, in chronic myeloid leukemia and evaluation of TEX101 immunogenicity

Annals of Saudi Medicine

Volumn 32, Issue 3, 2012, Pages 256-261

  Ghafouri Fard, Soudeh ^a   Modarressi, Mohammad Hossein ^b   Yazarloo, Fatemeh ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER TESTIS ANTIGEN; OUTER DENSE FIBER OF SPERM TAILS 4; TESTIS EXPRESSED 101; UNCLASSIFIED DRUG;

ARTICLE; BLOOD SAMPLING; CANCER IMMUNOTHERAPY; CANCER INVASION; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; HUMORAL IMMUNITY; IMMUNOGENICITY; METASTASIS; NEOPLASM; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION;

ANTIGENS, NEOPLASM; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HEMATOLOGIC NEOPLASMS; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MEMBRANE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEMINAL PLASMA PROTEINS;

EID: 84865500743     PISSN: 02564947     EISSN: 09754466     Source Type: Journal    
DOI: 10.5144/0256-4947.2012.256     Document Type: Article

References (21)

1. Michor F, Iwasa Y, Nowak MA. The age incidence of chronic myeloid leukemia can be explained by a one-mutation model. Proc Natl Acad Sci U S A 2006;103:14931-4. (Pubitemid 44527831)
2. Dym M, Fawcett DW. The blood-testis barrier in the rat and the physiological compartmentation of the seminiferous epithelium. Biol Reprod 1970;3:308-26.
3. Fawcett DW, Leak LV, Heidger PM Jr. Electron microscopic observations on the structural components of the blood-testis barrier. J Reprod Fertil Suppl 1970;10:105-22.
4. Pelletier RM, Byers SW. The blood-testis barrier and Sertoli cell junctions: Structural considerations. Microsc Res Tech 1992;20:3-33.
5. Costa FF, Le Blanc K, Brodin B. Concise review: Cancer/testis antigens, stem cells, and cancer. Stem Cells 2007;25:707-11. (Pubitemid 46354230)
6. Meklat F, Li Z, Wang Z, Zhang Y, Zhang J, Jewell A, et al. Cancer- testis antigens in haematological malignancies. Br J Haematol 2007;136:769-76. (Pubitemid 46348406)
7. Nakamura Y, Tanaka H, Koga M, Miyagawa Y, Iguchi N, Egydio de Carvalho C, et al. Molecular cloning and characterization of oppo 1: A haploid germ cell-specific complementary DNA encoding sperm tail protein. Biol Reprod 2002;67:1-7. (Pubitemid 34680628)
8. Kitamura K, Miyagawa Y, Iguchi N, Nishimura H, Tanaka H, Nishimune Y. Molecular cloning and characterization of the human orthologue of the oppo 1 gene encoding a sperm tail protein. Mol Hum Reprod 2003;9:237-43. (Pubitemid 36748826)
9. Miyamoto T, Sengoku K, Hayashi H, Sasaki Y, Takuma N, Yamashita T, et al. Isolation and expression analysis of the testis-specific gene, human OPP O1. J Assist Reprod Genet 2004;21:129-34. (Pubitemid 38860205)
10. Ghafouri-Fard S, Abbasi A, Moslehi H, Faramarzi N, Taba Taba Vakili S, Mobasheri MB, et al. Elevated expression levels of testis-specific genes TE X101 and SPATA19 in basal cell carcinoma and their correlation with clinical and pathological features. Br J Dermatol 2010;162:772-9.
11. Ghafouri-Fard S, Ousati Ashtiani Z, Sabah Golian B, Hasheminasab SM, Modarressi MH. Expression of two testis-specific genes, SPATA19 and LEMD1, in prostate cancer. Arch Med Res 2010;41:195-200.
12. Yin LL, Chung CM, Chen J, Fok KL, Ng CP, Jia RR, et al. A suppressor of multiple extracellular matrix-degrading proteases and cancer metastasis. J Cell Mol Med 2009;13:4034-41.
13. Savona M, Talpaz M. Getting to the stem of chronic myeloid leukaemia. Nat Rev Cancer 2008;8:341-50. (Pubitemid 351589698)
14. Kanojia D, Garg M, Saini S, Agarwal S, Kumar R, Suri A. Sperm associated antigen 9 expression and humoral response in chronic myeloid leukemia. Leuk Res 2010;34:858-63.
15. Tanaka R, Ono T, Sato S, Nakada T, Koizumi F, Hasegawa K, et al. Over-expressin of the Testis- Specific Gene TSGA10 in cancers and its immunogenicity. Microbiol Immunol 2004;48:339-45. (Pubitemid 38508675)
16. Kocher T, Zheng M, Bolli M, Simon R, Forster T, Schultz-Thater E, et al. Prognostic relevance of MAGE -A4 tumor antigen expression in transitional cell carcinoma of the urinary bladder: A tissue microarray study. Int J Cancer 2002;100:702-5. (Pubitemid 34832982)
17. Bodey B, Siegel SE, Kaiser HE. MAGE -1, a cancer/ testis-antigen, expression in childhood astrocytomas as an indicator of tumor progression. In Vivo 2002;16:583-8. (Pubitemid 35460373)
18. Chitale DA, Jungbluth AA, Marshall DS, Leitao MM, Hedvat CV, Kolb D, et al. Expression of cancertestis antigens in endometrial carcinomas using a tissue microarray. Mod Pathol 2005;18:119-26. (Pubitemid 40128104)
19. Farias-Eisner R, Vician L, Silver A, Reddy S, Rabbani SA, Herschman HR. The urokinase plasminogen activator receptor (UPAR) is preferentially induced by nerve growth factor in PC 12 pheochromocytoma cells and is required for NGF - driven differentiation. J Neurosci 2000;20:230-9. (Pubitemid 30220510)
20. Ghafouri-Fard S, Modarressi MH. Cancer-Testis Antigens: Potential targets for cancer immunotherapy. Arch Iran Med 2009;12:395-404.
21. Akers SN, Odunsi K, Karpf AR. Regulation of cancer germline antigen gene expression: Implications for cancer immunotherapy. Future Oncol 2010;6:717-32.